Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
LC350189 in gout with hyperuricemia
NCT03934099Phase 2Completed
- Sponsor
- LG Chem
- Start
- Dec 2019
- Primary completion
- May 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of tigulixostat in gout, hyperuricemia, sponsored by LG Chem. Started Dec 2019; status: completed.
02
Drugs
tigulixostat
03
Conditions
gouthyperuricemia
Beyond the preview
Go deeper on NCT03934099.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03934099.